Status:
COMPLETED
A Pilot Study to Investigate Biomarkers in Anterior Cruciate Ligament (ACL) Patients and Healthy Controls
Lead Sponsor:
United Lincolnshire Hospitals NHS Trust
Collaborating Sponsors:
University of Lincoln
Conditions:
Rupture of Anterior Cruciate Ligament
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Incident rates of ACL rupture are greatest in 16-39 year olds at almost 1 in 1,000. Performance Based Investigations (PBIs) can be used to evaluate and select correct approaches to patient treatment,...
Eligibility Criteria
Inclusion
- unilateral ACL rupture
- 18 - 45 years old
Exclusion
- combined posterior and ACL rupture
- multi-ligament instability including medial or lateral collateral ligament injury
- other lower limb surgery \<3mths
- current significant acute injury affecting other lower extremity joints, or other relevant neurological or musculoskeletal pathology.
Key Trial Info
Start Date :
January 5 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 20 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT02300012
Start Date
January 5 2015
End Date
May 20 2022
Last Update
May 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
United Lincolnshire Hospitals NHS Trust
Lincoln, Lincolnshire, United Kingdom, LN2 5QY